🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Split 2:1 del 28/01/2013

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

6.181.783

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 3 días
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
15/06/2026 0,8200 USD
13/03/2026 0,8200 USD
15/12/2025 0,7900 USD
15/09/2025 0,7900 USD
13/06/2025 0,7900 USD
14/03/2025 0,7900 USD
13/12/2024 0,7700 USD
13/09/2024 0,7700 USD
14/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7500 USD
14/09/2023 0,7500 USD
14/06/2023 0,7500 USD
14/03/2023 0,7500 USD
14/12/2022 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
28/01/2013 2:1
25/06/2007 2:1
07/09/2004 2:1
08/03/2002 2:1
22/02/2001 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/02/2015 97,01 98,67 96,63 96,90 -0,59% 2,10% 12.668.500
06/02/2015 99,73 100,58 97,15 97,48 -2,42% 3,44% 21.546.300
05/02/2015 98,92 100,92 97,30 99,90 +1,49% 3,66% 20.641.500
04/02/2015 98,93 100,21 95,81 98,43 -8,16% 4,45% 59.415.800
03/02/2015 106,71 107,31 104,10 107,18 +0,93% 3,01% 19.849.900
02/02/2015 106,10 107,19 104,43 106,19 +1,30% 2,60% 13.965.600
30/01/2015 104,33 106,27 103,73 104,83 +0,62% 2,43% 13.608.200
29/01/2015 102,50 104,51 101,07 104,18 +1,69% 3,36% 8.410.500
28/01/2015 105,32 105,50 102,35 102,45 -2,46% 2,99% 11.554.500
27/01/2015 105,94 107,02 104,86 105,03 -1,94% 2,04% 10.341.100
26/01/2015 104,87 107,77 104,87 107,11 +1,49% 2,77% 10.307.500
23/01/2015 104,40 106,11 103,80 105,54 +0,38% 2,21% 9.593.500
22/01/2015 104,14 105,18 101,56 105,14 +1,51% 3,48% 12.963.100
21/01/2015 103,04 105,07 102,57 103,58 -0,19% 2,43% 12.312.500
20/01/2015 101,14 104,05 100,15 103,78 +3,05% 3,86% 18.838.100
16/01/2015 97,42 100,89 97,07 100,71 +3,40% 3,92% 14.097.700
15/01/2015 99,30 100,39 97,23 97,40 -1,87% 3,18% 11.442.200
14/01/2015 96,00 100,09 95,71 99,26 +2,11% 4,56% 16.183.700
13/01/2015 101,85 101,88 95,25 97,21 -3,95% 6,51% 27.030.600
12/01/2015 102,84 103,34 100,76 101,21 -0,98% 2,51% 12.746.000
09/01/2015 103,52 103,83 101,75 102,21 -0,09% 2,01% 14.738.100
08/01/2015 100,80 102,45 100,29 102,30 +2,83% 2,14% 18.902.300
07/01/2015 99,31 99,90 98,44 99,48 +1,87% 1,47% 16.373.700
06/01/2015 98,47 99,34 96,09 97,65 +0,89% 3,30% 22.363.800
05/01/2015 95,24 98,73 93,18 96,79 +1,98% 5,83% 27.530.400
02/01/2015 95,14 96,65 94,52 94,91 +0,69% 2,24% 12.340.200
31/12/2014 96,00 96,75 94,24 94,26 -1,07% 2,61% 13.879.000
30/12/2014 97,74 98,24 95,07 95,28 -2,08% 3,24% 18.488.400
29/12/2014 96,07 97,42 95,40 97,30 +3,74% 2,10% 20.634.000
26/12/2014 92,76 94,36 92,31 93,79 +2,74% 2,21% 17.649.600